Cancer-related coagulopathies

Thrombosis Research

Volumn 133, Issue SUPPL. 2, 2014, Pages

  Levi, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer; Coagulopathy; Disseminated intravascular coagulation; Endothelium; Microangiopathy; Thrombosis

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; CANCER PROCOAGULANT; CYSTEINE PROTEINASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ELASTASE; MUCIN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ARTICLE; ARTIFICIAL EMBOLISM; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CACHEXIA; CANCER PATIENT; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN METABOLISM; FIBRINOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERCOAGULABILITY; INJURY; METASTASIS; MICROANGIOPATHY; NEOPLASM; NONHUMAN; OCCULT CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROTEIN INTERACTION; SEPSIS; THROMBOCYTE ACTIVATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM; VEIN OCCLUSION; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD COAGULATION DISORDERS; CHEMORADIOTHERAPY; COMPLICATION; NEOPLASMS;

BLOOD COAGULATION DISORDERS; CHEMORADIOTHERAPY; HUMANS; NEOPLASMS; VENOUS THROMBOEMBOLISM;

EID: 84901394189     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(14)50012-6     Document Type: Article

References (88)

1. M. Levi Cancer and DIC Haemostasis 31 Suppl 1 2001 47 48
2. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
3. M. Levi Disseminated intravascular coagulation in cancer patients Best Pract Res Clin Haematol 22 2009 129 136
4. H.C. Kwaan, and L.I. Gordon Thrombotic microangiopathy in the cancer patient Acta Haematol 106 2001 52 56 (Pubitemid 32830516)
5. T. Barbui, and A. Falanga Disseminated intravascular coagulation in acute leukemia Semin Thromb Hemost 27 2001 593 604 (Pubitemid 33152572)
6. A. Falanga, L. Russo, and C. Verzeroli Mechanisms of thrombosis in cancer Thromb Res 131 Suppl 1 2013 S59 S62
7. A. Falanga, M. Marchetti, and A. Vignoli Coagulation and cancer: biological and clinical aspects J Thromb Haemost 11 2013 223 233
8. M. Levi Molecular medicine: Promises and patience Neth J Med 71 2013 107 108
9. M.B. Donati Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice Thromb Haemost 74 1995 278 281
10. M. Levi Cancer and thrombosis Clin Adv Hematol Oncol 1 2003 668 671
11. J. Contrino, G. Hair, D.L. Kreutzer, and F.R. Rickles In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease Nature Medicine 2 1996 209 215 (Pubitemid 26054985)
12. F.R. Rickles, and B. Brenner Tissue factor and cancer Semin Thromb Hemost 34 2008 143 145
13. M.E. Bromberg, W.H. Konigsberg, J.F. Madison, A. Pawashe, and A. Garen Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation Proc Natl Acad Sci U S A 92 1995 8205 8209
14. Y. Zhang, Y. Deng, T. Luther, M. Muller, R. Ziegler, and R. Waldherr et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice J Clin Invest 94 1994 1320 1327 (Pubitemid 24286478)
15. Y. Nadir, I. Vlodavsky, and B. Brenner Heparanase, tissue factor, and cancer Semin Thromb Hemost 34 2008 187 194
16. A. Falanga, R. Consonni, M. Marchetti, G. Locatelli, E. Garattini, and C.G. Passerini et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells Blood 92 1998 143 151 (Pubitemid 28303186)
17. M. Levi Disseminated intravascular coagulation in cancer patients Best Pract Res Clin Haematol 22 2009 129 136
18. J.E. Geddings, and N. Mackman Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients Blood 122 2013 1873 1880
19. M. Wahrenbrock, L. Borsig, and M. Le Duc Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinoma J Clin Invest 112 2003 853
20. H.F. Dvorak, S.C. Quay, and N.S. Orenstein Tumor shedding and coagulation Science 212 1981 923
21. B. Furie, and B.C. Furie Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation Trends Mol Med 10 2004 171 178 (Pubitemid 38410975)
22. J.I. Zwicker Tissue factor-bearing microparticles and cancer Semin Thromb Hemost 34 2008 195 198
23. S. Sallah, J.Y. Wan, N.P. Nguyen, L.R. Hanrahan, and G. Sigounas Disseminated intravascular coagulation in solid tumors: clinical and pathological study Thromb Haemost 86 2001 828 833 (Pubitemid 32834193)
24. M.R. Nijziel, R. Van Oerle, H.F. Hillen, and K. Hamulyak From Trousseau to angiogenesis: the link between the haemostatic system and cancer Neth J Med 64 2006 403 410 (Pubitemid 46001908)
25. F.R. Rickles, and A. Falanga Molecular basis for the relationship between thrombosis and cancer Thromb Res 102 2001 V215 V224
26. M. Levi, T. Van Der Poll, H. ten Cate, and S.J. Van Deventer The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia Eur J Clin Invest 27 1997 3 9 (Pubitemid 27065166)
27. J.M. Stouthard, M. Levi, C.E. Hack, C.H. Veenhof, H.A. Romijn, and H.P. Sauerwein et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans Thromb Haemost 76 1996 738 742 (Pubitemid 26388179)
28. T. Van Der Poll, S.M. Coyle, M. Levi, P.M. Jansen, M. Dentener, and K. Barbosa et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans Blood 89 1997 3727 3734 (Pubitemid 27227096)
29. T. Van Der Poll, M. Levi, H. ten Cate, and S.J. Van Deventer The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia Prog Clin Biol Res 388 1994 425 433
30. T. Van Der Poll, M. Levi, S.J. Van Deventer, H. ten Cate, B.L. Haagmans, and B.J. Biemond et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees Blood 83 1994 446 451 (Pubitemid 24030570)
31. M.E. Sewnath, D.P. Olszyna, R. Birjmohun, F.J. ten Kate, D.J. Gouma, and T. Van Der Poll IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance J Immunol 166 2001 6323 6331 (Pubitemid 32440765)
32. T. Van Der Poll, J. Jansen, M. Levi, H. ten Cate, C.E. Hack, and L.A. Aarden et al. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6 Scand J Immunol 43 1996 122 125 (Pubitemid 26024536)
33. T. Van Der Poll, P.M. Jansen, W.J. Montegut, C.C. Braxton, S.E. Calvano, and S.A. Stackpole et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia J Immunol 158 1997 1971 1975 (Pubitemid 127469558)
34. E. Holler, H.J. Kolb, E. Hiller, W. Mraz, W. Lehmacher, and B. Gleixner et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation Blood 73 1989 2018 2024 (Pubitemid 19145140)
35. P.W. Collins, C.N. Gutteridge, A. O'Driscoll, S. Blair, L. Jones, and R. Aitchison et al. von Willebrand factor as a marker of endothelial cell activation following BMT Bone Marrow Transplant 10 1992 499 506 (Pubitemid 23024733)
36. M.C. Bertomeu, S. Gallo, D. Lauri, M.N. Levine, F.W. Orr, and M.R. Buchanan Chemotherapy enhances endothelial cell reactivity to platelets Clin Exp Metastasis 8 1990 511 518 (Pubitemid 20355466)
37. E.M. Conway, M. Van de Wouwer, S. Pollefeyt, K. Jurk, H. Van Aken, and A. De Vriese et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways J Exp Med 196 2002 565 577 (Pubitemid 35024436)
38. M. Levi, J.W. ten Cate, G. Dooijewaard, A. Sturk, E.J. Brommer, and G. Agnelli DDAVP induces systemic release of urokinase-type plasminogen activator Thromb Haemost 62 1989 686 689 (Pubitemid 19267418)
39. M. Levi, H. ten Cate, and T. Van Der Poll Endothelium: interface between coagulation and inflammation Crit Care Med 30 2002 S220 S224
40. C. Seeber, E. Hiller, E. Holler, and H.J. Kolb Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT) Thromb Res 66 1992 373 383
41. M.E. Chappell, D.M. Keeling, H.G. Prentice, and P. Sweny Haemolytic uraemic syndrome after bone marrow transplantation: An adverse effect of total body irradiation? Bone Marrow Transplant 3 1988 339 347
42. H. Cohen, H.A. Bull, A. Seddon, M.S. Enayat, F.G. Hill, and N. Woolf et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation Eur J Haematol 43 1989 207 214 (Pubitemid 19252202)
43. D. Charba, J.L. Moake, M.A. Harris, and J.P. Hester Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies Am J Hematol 42 1993 268 277 (Pubitemid 23079880)
44. M. Franchini, M. Montagnana, G. Targher, and G. Lippi Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases Semin Thromb Hemost 33 2007 787 797 (Pubitemid 351158447)
45. S.A. Gregory, J.H. Morrissey, and T.S. Edgington Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin Mol Cell Biol 9 1989 2752 2755 (Pubitemid 19148149)
46. T. Koyama, K. Nishida, S. Ohdama, M. Sawada, N. Murakami, and S. Hirosawa et al. Determination of plasma tissue factor antigen and its clinical significance Br J Haematol 87 1994 343 347 (Pubitemid 24204737)
47. E.M. Conway, and R.D. Rosenberg Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells Mol Cell Biol 8 1988 5588 5592
48. D. Collen On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture Thromb Haemost 43 1980 77 89 (Pubitemid 10063059)
49. H. Wada, T. Kaneko, M. Ohiwa, M. Tanigawa, T. Hayashi, and S. Tamaki et al. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura Am J Hematol 44 1993 101 105 (Pubitemid 23269715)
50. P.W. Straub Diffuse intravascular coagulation in liver disease? Semin Thromb Hemost 4 1977 29 39 (Pubitemid 8195086)
51. M. Levi Disseminated intravascular coagulation: A disease-specific approach Semin Thromb Hemost 36 2010 363 365
52. U. Seligsohn Disseminated Intravascular Coagulation R.I. Handin, S.E. Lux, T.P. Stossel, Blood: Pinciples and Practice of Hematology 2000 J.B.Lippingcott Philadelphia
53. J.A. Lopez, R.S. Ross, M.C. Fishbein, and R.J. Siegel Nonbacterial thrombotic endocarditis: A review Am Heart J 113 1987 773 784 (Pubitemid 17036729)
54. G.H. Sack Jr., J. Levin, and W.R. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features Medicine (Baltimore) 56 1977 1 37 (Pubitemid 8029158)
55. A. Trousseau Phlegmasia alba dolens Clin Med Hotel Dieu Paris 1865 695
56. K.E. Goad, and H.R. Gralnick Coagulation disorders in cancer Hematol Oncol Clin North Am 10 1996 457
57. J.T. Illtyd, and N.M. Matheson Thrombophlebitis in cancer Practitioner 134 1935 683 684
58. H.M. Otten, and M.H. Prins Venous thromboembolism and occult malignancy Thromb Res 102 2001 V187 V194
59. F.W. Leebeek, J.H. Smalberg, and H.L. Janssen Prothrombotic disorders in abdominal vein thrombosis Neth J Med 70 2012 400 405
60. H.J. Tagnon, W.F. Whitmore, and N.R. Shulman Fibrinolysis in metastatic cancer of the prostate Cancer 5 1952 9 12
61. A. Falanga Mechanisms of hypercoagulation in malignancy and during chemotherapy Haemostasis 28 Suppl 3 1998 50 60 (Pubitemid 29049321)
62. M.H. Prins, R.J. Hettiarachchi, A.W. Lensing, and J. Hirsh Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see? Thromb Haemost 78 1997 121 125 (Pubitemid 27289228)
63. R.J. Hettiarachchi, J. Lok, M.H. Prins, H.R. Buller, and P. Prandoni Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis Cancer 83 1998 180 185 (Pubitemid 28299645)
64. A. Kleinjan, F.F. Van Doormaal, M.H. Prins, H.R. Buller, and J.M. Otten Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism Neth J Med 70 2012 311 317
65. M.R. Nijziel To screen or not to screen patients with an idiopathic venous thrombosis for an occult cancer: Netherlands versus the world: 1-0? Neth J Med 70 2012 296 297
66. J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study Arch Intern Med 160 2000 761 768 (Pubitemid 30165236)
67. M. Zangari, E. Anaissie, B. Barlogie, A. Badros, R. Desikan, and A.V. Gopal et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy Blood 98 2001 1614 1615
68. A.A. Desai, N.J. Vogelzang, B.I. Rini, R. Ansari, S. Krauss, and W.M. Stadler A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma Cancer 95 2002 1629 1636
69. B.C. Kuenen, L. Rosen, E.F. Smit, M.R. Parson, M. Levi, and R. Ruijter et al. Dosefinding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors J Clin Oncol 20 2002 1657 1667 (Pubitemid 34260548)
70. B.C. Kuenen, M. Levi, J.C. Meijers, A.K. Kakkar, V.W.M. Van Hinsbergh, and P.J. Kostense et al. Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients Arterioscler Thromb Vasc Biol 22 2002 1500 1505
71. S. Van Wissen, B.A. Bastiaansen, A.K. Stroobants, E.J. Van den Dool, M.M. Idu, and M. Levi et al. Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour-a case report Lupus 17 2008 586 590 (Pubitemid 351955436)
72. D.C. Doll, and J.W. Yarbro Vascular toxicity associated with antineoplastic agents Semin Oncol 19 1992 580 596
73. A.R. Pettitt, and R.E. Clark Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 14 1994 495 504 (Pubitemid 24338473)
74. H.W. Snyder Jr., A. Mittelman, A. Oral, G.L. Messerschmidt, D.H. Henry, and S. Korec et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma Cancer 71 1993 1882 1892 (Pubitemid 23067409)
75. E.C. Guinan, N.J. Tarbell, C.M. Niemeyer, S.E. Sallan, and H.J. Weinstein Intravascular hemolysis and renal insufficiency after bone marrow transplantation Blood 72 1988 451 455
76. C. Antignac, M.C. Gubler, G. Leverger, M. Broyer, and R. Habib Delayed renal failure with extensive mesangiolysis following bone marrow transplantation Kidney Int 35 1989 1336 1344 (Pubitemid 19167926)
77. S.N. Rabinowe, R.J. Soiffer, N.J. Tarbell, D. Neuberg, A.S. Freedman, and J. Seifter et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies Blood 77 1991 1837 1844
78. A.M. Jackson, B.D. Rose, L.G. Graff, J.B. Jacobs, J.H. Schwartz, and G.M. Strauss et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy Ann Intern Med 101 1984 41 44 (Pubitemid 14088065)
79. T. Barbui, G. Finazzi, and A. Falanga Myeloproliferative neoplasms and thrombosis Blood 122 2013 2176 2184
80. A.H. Sarris, S. Kempin, E. Berman, J. Michaeli, C. Little, and M. Andreeff et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia Blood 79 1992 1305 1310
81. G. Avvisati, J.W. ten Cate, A. Sturk, R. Lamping, M.G. Petti, and F. Mandelli Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia Br J Haematol 70 1988 43 48
82. M. Franchini, M.N. Di Minno, and A. Coppola Disseminated intravascular coagulation in hematological malignancies Semin Thromb Hemost 36 2010 388 403
83. H.R. Gralnick, and P. Greipp Thrombosis with epsilon aminocaproic acid therapy Am J Clin Pathol 56 1971 151 154
84. T. Barbui, G. Finazzi, and A. Falanga The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia Blood 91 1998 3093 3102 (Pubitemid 28193856)
85. F. Rodeghiero, and G. Castaman The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia Leukemia 8 Suppl 2 1994 S20 S26
86. M. Franchini, M.N. Di Minno, and A. Coppola Disseminated intravascular coagulation in hematologic malignancies Semin Thromb Hemost 36 2010 388 403
87. M.S. Tallman The thrombophilic state in acute promyelocytic leukemia Semin Thromb Hemost 25 1999 209 215
88. E. Stein, B. McMahon, H. Kwaan, J.K. Altman, O. Frankfurt, and M.S. Tallman The coagulopathy of acute promyelocytic leukaemia revisited Best Pract Res Clin Haematol 22 2009 153 163